HOSPITAL UNIVERSITARIO INFANTA SOFÍA
Departamento
ISRAEL JOHN
THUISSARD VASALLO
PROFESOR DOCTOR
Publicaciones en las que colabora con ISRAEL JOHN THUISSARD VASALLO (29)
2024
-
An Observational Study in the Real Clinical Practice of the Treatment of Noninfectious Uveitis
Journal of Clinical Medicine, Vol. 13, Núm. 5
-
Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial
Scientific Reports, Vol. 14, Núm. 1
-
Impact of systemic therapies on SARS-CoV-2 antibody seroprevalence in patients with immune-mediated diseases
Medicina Clinica
2023
-
AB1352 Impact of Systemic Therapies on the Seroprevalence of Sars-Cov-2 in Patients with Immune-Mediated Diseases
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 1907.1-1907
-
POS0793-HPR Observational Study in Real Clinical Practice of the Treatment of Non-Infectious Uveitis
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 689.2-690
-
Result of the update of the clinical pathway for hip fracture in the older adult at a university hospital in Madrid
Revista Espanola de Geriatria y Gerontologia, Vol. 58, Núm. 2, pp. 61-67
-
Seroprevalence of SARS-CoV-2 antibodies in patients with immune-mediated inflammatory diseases treated with biological and synthetic targeted therapies
Revista Chilena de Infectologia, Vol. 40, Núm. 6, pp. 618-625
-
The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors
Vaccines, Vol. 11, Núm. 10
2022
-
Accuracy, feasibility and predictive ability of different frailty instruments in an acute geriatric setting
European Geriatric Medicine, Vol. 13, Núm. 4, pp. 827-835
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs-Findings From the BIOCOVID Study
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 28, Núm. 2, pp. e348-e352
-
Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
JCR: Journal of Clinical Rheumatology, Vol. 28, Núm. 2, pp. e348-e352
2021
-
Clinical Characteristics, Frailty, and Mortality of Residents With COVID-19 in Nursing Homes of a Region of Madrid
Journal of the American Medical Directors Association, Vol. 22, Núm. 2, pp. 245-252.e2
-
Effect of intravenous iron on functional outcomes in hip fracture: A randomised controlled trial
Age and Ageing, Vol. 50, Núm. 1, pp. 127-134
-
Impact of biological therapies on the immune response after pneumococcal vaccination in patients with autoimmune inflammatory diseases
Vaccines, Vol. 9, Núm. 3, pp. 1-12
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
-
Muscle Assessment by Ultrasonography: Agreement with Dual-Energy X-Ray Absorptiometry (DXA) and Relationship with Physical Performance
Journal of Nutrition, Health and Aging, Vol. 25, Núm. 8, pp. 956-963
-
Ras mutational status in advanced colorectal adenocarcinoma treated with anti-angiogenics: Preliminary experience with liquid biopsy
In Vivo, Vol. 35, Núm. 5, pp. 2841-2844
2020
-
AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis
Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study
Clinical Rheumatology, Vol. 39, Núm. 9, pp. 2751-2756